Results 41 to 50 of about 13,691 (157)
BackgroundPostmarketing pharmacovigilance data have raised concerns regarding the potential cognitive effects associated with finasteride administration.
Hao Zhang +5 more
doaj +1 more source
Background Benign prostatic hyperplasia affects older men. This systematic review determined efficacy and adverse effects of finasteride. Review methods PubMed, the Cochrane Library, reference lists of reports, and reviews were searched for randomised ...
Moore R Andrew, Edwards Jayne E
doaj +1 more source
Metabolism of anabolic androgenic steroids is important for its physiological effects. The aim was to investigate the effects of finasteride (a 5α-reductase inhibitor - 5αR) on cardiac and mutagenic effects promoted by ND. Male Wistar rats were separated
Elizângela Faustino Da Mata +8 more
doaj +1 more source
Abstract Objective To evaluate the synergistic effect and safety of sublingual isosorbide dinitrate (ISDN) to facilitate successful voiding trial after catheterization for acute urinary retention (AUR) secondary to benign prostatic hyperplasia (BPH). Material and methods In this randomized clinical trial, male patients aged ≥ 50 years presenting with ...
Salman Soltani +5 more
wiley +1 more source
Topical Finasteride in Hirsutism: A Double Blind Randomized Clinical Trial on Adult Women
Background: Finasteride partially blocks the conversion of testosterone to dihydrotestosterone through inhibition of 5 α- reductase in hair follicles. Finasteride cream can penetrate to dermis to arrive at hair follicle due to its solubility.
F Iraji, S Karbasioun, A Aminorroaya
doaj
ABSTRACT Background and Aims Androgenic alopecia (AGA) is a prevalent form of hair loss characterized by progressive miniaturization of hair follicles, significantly impacting patients’ self‐confidence and quality of life. Current FDA‐approved treatments demonstrate limited to moderate efficacy.
Elham Behrangi +4 more
wiley +1 more source
Lipid and Foam Cell Accumulation as Novel Pathological Features of Benign Prostatic Hyperplasia
ABSTRACT Background Benign prostatic hyperplasia (BPH) encompasses a heterogeneous set of pathological processes that instigate lower urinary tract symptoms (LUTS). Using a mouse model of steroid hormone imbalance–induced lower urinary tract dysfunction, we identified luminal lipid‐laden foamy macrophages, although their presence and contribution to ...
Dita Julianingsih +9 more
wiley +1 more source
Post-finasteride syndrome: our current knowledge
5-α reductase inhibitors are effective and commonly used medications for the treatment of benign prostatic hyperplasia. However, there are some questions about the safety of such medications.
A. A. Galushkin +2 more
doaj +1 more source
Exogenous testosterone and stress can cause severe oxidative stress and inflammation in the testicles. To combat testicular damage caused by testosterone and stress, we developed a nanoemulsion containing quercetin and black seed oil. This innovative formulation significantly enhanced antioxidant defences, reduced inflammation and prevented ...
Majid Najafi +3 more
wiley +1 more source
Screening and confirmation methods of the major urinary metabolite of finasteride–carboxy-finasteride for doping control purpose were developed. Liquid–liquid extraction was adopted for the sample preparation.
Jianli Zhang
doaj +1 more source

